Related Experiment Videos
Experimental cardiac allograft vasculopathy in mice
A Ardehali1, A Billingsley, H Laks
1Department of Surgery, UCLA Medical Center 90024.
Summary
A new mouse model for cardiac allograft vasculopathy (CAV) was developed using heterotopic heart transplantation. This model mimics clinical CAV, enabling further research into its causes and treatments.
Area of Science:
- Transplantation Immunology
- Cardiovascular Pathology
- Murine Models
Background:
- Cardiac allograft vasculopathy (CAV) is a primary cause of late mortality in heart transplant recipients.
- The precise pathogenesis of CAV remains incompletely understood.
- A well-defined animal model is crucial for studying CAV.
Purpose of the Study:
- To establish a reproducible murine model for cardiac allograft vasculopathy.
- To characterize the vascular pathology in a heterotopic heart transplant mouse model.
- To provide a platform for investigating CAV pathogenesis and therapeutic strategies.
Main Methods:
- Heterotopic intraabdominal heart transplantation between B10.A (donor) and B10.BR (recipient) inbred mice.
- No immunosuppressive therapy was administered.
- Allografts were harvested at 30 and 50 days post-operation for pathological analysis.
Main Results:
- Allografts exhibited acute cellular rejection and characteristic CAV lesions, including intimal thickening, mononuclear cell infiltration, fibrosis, internal elastic lamina disruption, and perivascular inflammation.
- Intimal thickening was observed in 55% +/- 26% and 60% +/- 18% of arteries at 30 and 50 days, respectively.
- Isografts showed no vascular lesions, confirming the allogeneic nature of the observed pathology.
Conclusions:
- Heterotopic heart transplantation between B10.A and B10.BR mice provides a valuable murine model for studying cardiac allograft vasculopathy.
- This model recapitulates key pathological features of clinical CAV.
- It serves as a foundation for future research into the mechanisms and treatment of CAV.